BROWSE·page 277 of 611

Browse EX-10 agreements

7,325 matching material contract exhibits.


EXHIBIT 10.2

RUSH ENTERPRISES INC \TX\

FIFTH AMENDMENT TO THE

FIRST AMENDED AND RESTATED BMO WHOLESALE FINANCING AND SECURITY AGREEMENT

THIS FIFTH AMENDMENT TO THE AMENDED AND RESTATED BMO WHOLESALE FINANCING AND SECURITY

**AGREEMENT (this “AMENDMENT” **) is made as of and with effect from the 4th day of Augustly 2026, between **BANK OF MONTREAL **(“BMO”), as lender, **RUSH TRUCK CENTRES OF CANADA LIMITED **(“DEALER”), as borrower, and RUSH ENTERPRISES, INC., as guarantor (“HOLDINGS”).

CONTEXT OF AGREEMENT

…

EX-10.2·8-K·CIK 1012019·ACC 0001437749-26-025981·Filed Aug 05, 2026, 18:14 ET

EX-10.1

National Healthcare Properties, Inc.

Execution Version

AMENDED AND RESTATED CREDIT AGREEMENT

Dated as of August 3, 2026

    by and among    

NATIONAL HEALTHCARE PROPERTIES, INC.,

as Parent,

NATIONAL HEALTHCARE PROPERTIES OPERATING PARTNERSHIP, L.P.,
as Borrower,

THE FINANCIAL INSTITUTIONS PARTY HERETO, ANY FINANCIAL INSTITUTIONS JOININGUNDER SECTION 2.17
AND THEIR ASSIGNEES UNDER SECTION 13.5,
as Lenders,

WELLS FARGO BANK, NATIONAL ASSOCIATION,
as Administrative Agent

_____________________________________________________

WELLS FARGO SECURITIES, LLC,BMO BANK N.A.,CITIZENS BANK, N.A., CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK, FIFTH THIRD BANK, NATIONAL ASSOCIATION, GOLDMAN SACHS BANK USA, THE HUNTINGTON NATIONAL BANK,KEYBANC CAPITAL MARKETS INC.,MORGAN STANLEY SENIOR FUNDING, INC.,RBC CAPITAL MARKETS, and TRUIST SECURITIES, INC.
as Joint Lead Arrangers,

WELLS FARGO SECURITIES, LLCand BMO BANK N.A.

as Joint Bookrunners,

BMO BANK N.A.,
as Syndication Agent,

and

…

EX-10.1·8-K·CIK 1561032·ACC 0001561032-26-000052·Filed Aug 05, 2026, 17:25 ET

EXHIBIT 10.1

AMASS BRANDS


Exhibit 10.1


SIDE LETTER AGREEMENT

This Side Letter Agreement (“Agreement”) is effective as of July 29, 2026 (the “Effective Date”) by and among Full Glass Wine Co., a Delaware limited liability company (“FGWC”), Full Glass - Licensing, LLC, a Delaware limited liability company (“Full Glass - Licensing,” and together with FGWC, “Full Glass”) and AMASS Brands Inc., a Delaware corporation (“AMASS”). Each of FGWC, Full Glass - Licensing and AMASS is referred to herein as a “Party” and collectively, the “Parties”.

** **

RECITALS

WHEREAS, Full Glass - Licensing and AMASS have entered into that certain Multi-Year Wine Purchase Agreement (“Multi-Year Wine Purchase Agreement”) dated February 29, 2024. Terms used but not defined in this Agreement shall have the meanings ascribed to them in the Multi-Year Wine Purchase Agreement;

…

EX-10.1·8-K·CIK 1851491·ACC 0001575872-26-000551·Filed Aug 05, 2026, 17:22 ET

EX-10.1

Glucotrack, Inc.

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of August 4, 2026, between Glucotrack, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

ARTICLE 1

DEFINITIONS

…

EX-10.1·8-K·CIK 1506983·ACC 0001493152-26-036218·Filed Aug 05, 2026, 17:20 ET

EX-10.2

Glucotrack, Inc.

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 4, 2026, between Glucotrack, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Purchaser (the “Purchase Agreement”).

The Company and the Purchaser hereby agree as follows:

ARTICLE 1

Definitions.

**Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. **As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section 6.3.

…

EX-10.2·8-K·CIK 1506983·ACC 0001493152-26-036218·Filed Aug 05, 2026, 17:20 ET

EX-10.1

COMPASS MINERALS INTERNATIONAL INC

August 2, 2026

Brandon,

I am pleased to confirm our discussion and offer of promotion to Chief Operating Officer effective August 3, 2026, reporting to me. Your new annual base salary will be $450,000.

•You will remain eligible for the Compass Minerals Management Annual Incentive Program (MAIP) and your incentive target will increase to 70% of your base salary effective August 3, 2026.

•You will remain eligible for the Compass Minerals Long Term Incentive Program (LTIP) and your new annual incentive target is $600,000 is comprised of 50% RSUs and 50% PSUs, beginning with the 2027 fiscal year grant (fiscal year beginning October 1, 2026).

•You will become a member of the Executive Leadership Team.

•You will be entitled to an annual executive physical paid for by CMP. You will also be eligible to participate in the Executive Disability Plan.

…

EX-10.1·8-K·CIK 1227654·ACC 0001227654-26-000051·Filed Aug 05, 2026, 17:18 ET

EXHIBIT 10.6

Vireo Growth Inc.

Exhibit 10.6

INVESTOR RIGHTS AGREEMENT

This Investor Rights Agreement (this “Agreement”) is made and entered into as of [●], 2026, by and between Vireo Growth Inc., a British Columbia corporation (“Parent”), [•], [•] (the “Stockholder”), in connection with that certain Securities Purchase Agreement (the “Purchase Agreement”), by and among Parent, the Stockholder, [•], [•] and [•] (the “Company”).

NOW THEREFORE IN CONSIDERATION of the mutual covenants contained in this Agreement and the Purchase Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parent and the Stockholder agree as follows:

ARTICLE I
DEFINITIONS

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. Notwithstanding the foregoing, as used in this Agreement, the following terms shall have the following meanings:

“Advice” has the meaning set forth in Article IV, Section 3.

…

EX-10.6·8-K·CIK 1771706·ACC 0001104659-26-091266·Filed Aug 05, 2026, 17:16 ET

EXHIBIT 10.4

Vireo Growth Inc.

Exhibit 10.4

SECURITIES PURCHASE AGREEMENT

by and among

VIREO GROWTH INC.,

REBECCA MYERS,

DIETRICH STEPHAN,

JOY BOCHNER,

CHICAGO ATLANTIC CREDIT OPPORTUNITIES, LLC,

and

FARMACEUTICALRX 2 LLC,

Dated as of July 30, 2026

Table of Contents

Page
ARTICLE I.       DEFINITIONS 2

…

EX-10.4·8-K·CIK 1771706·ACC 0001104659-26-091266·Filed Aug 05, 2026, 17:16 ET

EXHIBIT 10.3

Vireo Growth Inc.

INVESTOR RIGHTS AGREEMENT

This Investor Rights Agreement (this “Agreement”) is made and entered into as of [●], 2026, by and between Vireo Growth Inc., a British Columbia corporation (“Parent”), and **[SB Ohio Holdings Inc., an Ohio corporation][Chicago Atlantic Credit Opportunities, LLC, a Delaware limited liability company] **(the “Stockholder”), in connection with that certain Securities Purchase Agreement (the “Purchase Agreement”), by and among Parent, the Stockholder, **[Chicago Atlantic Credit Opportunities, LLC] [SB Ohio Holdings Inc.] **and FarmaceuticalRx LLC, an Ohio limited liability company (the “Company”).

**NOW THEREFORE IN CONSIDERATION **of the mutual covenants contained in this Agreement and the Purchase Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parent and the Stockholder agree as follows:

ARTICLE I
DEFINITIONS

…

EX-10.3·8-K·CIK 1771706·ACC 0001104659-26-091266·Filed Aug 05, 2026, 17:16 ET

EXHIBIT 10.5

Vireo Growth Inc.

Exhibit 10.5

LOCK-UP AGREEMENT

[●], 2026

Vireo Growth Inc.

Ladies and Gentlemen:

The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Vireo Growth Inc., a British Columbia corporation (“Parent”), has entered into that certain Securities Purchase Agreement, dated as of [●], 2026 (as the same may be amended from time to time, the “Purchase Agreement”) by and among Parent, Es] (the “Company”), Es], and Es]. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement.

…

EX-10.5·8-K·CIK 1771706·ACC 0001104659-26-091266·Filed Aug 05, 2026, 17:16 ET

EXHIBIT 10.2

Vireo Growth Inc.

EXHIBIT 10.2

LOCK-UP AGREEMENT

[●], 2026

Vireo Growth Inc.

Ladies and Gentlemen:

The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Vireo Growth Inc., a British Columbia corporation (“Parent”), has entered into that certain Securities Purchase Agreement, dated as of [●], 2026 (as the same may be amended from time to time, the “Purchase Agreement”) by and among Parent, FarmaceuticalRx LLC, an Ohio limited liability company (the “Company”), Chicago Atlantic Credit Opportunities, LLC, a Delaware limited liability company, and SB Ohio Holdings Inc., an Ohio corporation. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement.

…

EX-10.2·8-K·CIK 1771706·ACC 0001104659-26-091266·Filed Aug 05, 2026, 17:16 ET

EXHIBIT 10.1

Vireo Growth Inc.

Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

by and among

VIREO GROWTH INC.,

SB OHIO HOLDINGS INC.,
CHICAGO ATLANTIC CREDIT OPPORTUNITIES, LLC,

and

FARMACEUTICALRX LLC,

Dated as of July 30, 2026

Table of Contents

Page(s)
ARTICLE I. DEFINITIONS 2

…

EX-10.1·8-K·CIK 1771706·ACC 0001104659-26-091266·Filed Aug 05, 2026, 17:16 ET